Phase 1/2 Open label study of SL-401 with Pom/Dex in R/R MM
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Stemline Therapeutics, Inc
Start Date
May 1, 2016
End Date
April 30, 2021
Administered By
Duke Cancer Institute
Awarded By
Stemline Therapeutics, Inc
Start Date
May 1, 2016
End Date
April 30, 2021